Marshall Wace North America’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | $6.55M | Buy |
60,708
+46,459
| +326% | +$5.01M | 0.03% | 439 |
|
|
2021
Q2 | $1.61M | Sell |
14,249
-149,318
| -91% | -$16.8M | 0.01% | 845 |
|
|
2021
Q1 | $17.7M | Sell |
163,567
-288,542
| -64% | -$31.2M | 0.07% | 271 |
|
|
2020
Q4 | $48.4M | Sell |
452,109
-1,547,969
| -77% | -$166M | 0.22% | 122 |
|
|
2020
Q3 | $175M | Sell |
2,000,078
-1,298,961
| -39% | -$114M | 1.12% | 11 |
|
|
2020
Q2 | $324M | Buy |
3,299,039
+495,184
| +18% | +$48.6M | 2.14% | 4 |
|
|
2020
Q1 | $214M | Buy |
2,803,855
+764,094
| +37% | +$58.2M | 1.62% | 6 |
|
|
2019
Q4 | $181M | Buy |
2,039,761
+784,623
| +63% | +$69.5M | 0.87% | 28 |
|
|
2019
Q3 | $95M | Buy |
1,255,138
+523,132
| +71% | +$39.6M | 0.54% | 50 |
|
|
2019
Q2 | $53.2M | Buy |
732,006
+473,892
| +184% | +$34.5M | 0.33% | 82 |
|
|
2019
Q1 | $20.8M | Buy |
258,114
+26,928
| +12% | +$2.17M | 0.15% | 141 |
|
|
2018
Q4 | $21.3M | Buy |
231,186
+215,253
| +1,351% | +$19.8M | 0.21% | 101 |
|
|
2018
Q3 | $1.51M | Buy |
15,933
+3,533
| +28% | +$334K | 0.01% | 542 |
|
|
2018
Q2 | $1.15M | Buy |
12,400
+1,494
| +14% | +$138K | 0.01% | 897 |
|
|
2018
Q1 | $1.03M | Buy |
+10,906
| New | +$1.03M | 0.01% | 992 |
|
|
2017
Q3 | – | Sell |
-111,274
| Closed | -$8.12M | – | 1208 |
|
|
2017
Q2 | $8.12M | Buy |
111,274
+93,060
| +511% | +$6.79M | 0.06% | 372 |
|
|
2017
Q1 | $1.18M | Buy |
+18,214
| New | +$1.18M | 0.01% | 665 |
|
|
2013
Q4 | $1.37M | Buy |
+25,960
| New | +$1.37M | 0.03% | 345 |
|